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The results of this study therefore suggest that measurements of these HDL subfractions may provide better indicators of coronary risk than that of total plasma cholesterol which is frequently employed for this purpose but was indistinguishable between the two groups in the present study. Very-low-density lipoproteins (VLDL) are the vehicles by which triacylglycerol is transported from the liver to other tissues. Morphological studies have already demonstrated that VLDL-like particles first appear in hepatic endoplasmic reticulum (ER) and then move to the trans-Golgi region, from where VLDL are secreted into the bloodstream [ 1-31. The polypeptide apolipoprotein B (apo B) has been shown to be essential for the hepatic assembly and secretion of VLDL [4] . However, the kinetics of apo B transfer between the subcellular organides and the mechanisms of apo B association with lipid have yet to be fully elucidated. Studies of the kinetics of synthesis and assembly of VLDL in hepatocytes are clearly dependent upon the availability of a sensitive quantitative assay for apo B. However, until recently, little attention has been given to the quantification of the principal B apo-proteins: apo B-100 and apo B-48. Here we have employed a new immunoblotting/radio-iodination technique to quantify apo B-100 and apo B-48 in plasma lipoproteins and hepatic ER and Golgi fractions in the rat. A purified apo B standard was prepared from rat plasma total lipoproteins, by precipitation with tetramethyl urea (TMU) [ S ] , and separated into apo 8-100 and B-48 by SDS/ PAGE [6] on 3-20% (w/v) gradient gels. The gel slices containing apo B were solubilized in hydrogen peroxide and assayed for protein by the Lowry method [7] . Of the total apo B protein applied to gels, 42.5%, was derived from apo B-100 and 57.5% from apo B-48. The purified standard was employed in the quantification of apo B in hepatic subcellular fractions.
A quantitative immunoassay for apolipoprotein B in plasma lipoproteins
ER and Golgi (truns-and cis-elements) were prepared from whole rat livers, as previously described [8] , and a cocktail of proteinase inhibitors added to minimize enzymic degradation of apo B [9]. The subcellular fractions were then detergent-solubilized [ 101, and the apo B immunoprecipitated using sheep anti-human apo B as a primary antibody, and donkey anti-sheep/goat IgG as a secondary antibody [8] . The immunoprecipitates and their supernatants were delipidated, solubilized in SDSlPAGE sample buffer, and applied Abbreviations used: apo B, apolipoprotein B; ER. endoplasmic reticulum; TMU, tetramethyl urea; VLDL, very-low-density lipoproteins.
to 3-20% (w/v) gradient gels, together with a range of concentrations (1-40 pg) of the purified apo B standard. The apo B from duplicate gels was electroblotted on to nitrocellulose membrane [ 1 11. One blot was immunostained for apo B, and the other was taken for apo B quantification.
For specific immunostaining of apo B (Fig. l ) , blots were incubated in anti-human apo B (primary antibody), followed by biotinylated anti-sheep IgG (secondary antibody) and then avidin/alkaline phosphatase which was detected colorimetrically (Vectastain). For apo B quantification, blots were first stained with Amido Black, and then incubated in antihuman apo B, followed by anti-sheep IgG, and finally, '% protein A (1 pCi). Blots were washed and air-dried, and the nitrocellulose chips, containing the Amido Black-stained apo B-100 and apo B-48, were cut out and counted in a ycounter. To allow for changes in the specific activity of '2'iprotein A, a new apo B standard curve was prepared for each assay.
Preliminary results of the apo B concentrations (pg/rng o f subcellular fraction protein) from four separate livers were as follows [values represent mean ( k s.E.M.)] E R B-100 = 6.9 (0.3), B-48 = 20.7 ( 1.4); Golgi (trans): B-100 = 27.7 ( 1.6), B-48 = 72.9 (3.4); Golgi (cis): B-100 = 2 1.2 (0.9), B-48 = 50.9 (2.8). In the immunoprecipitates from subcellular fractions (Fig. 1) . the fine immunostained bands lying between apo B-100 and apo B-48 were not apparent in the Amido Blackstained preparations. These did not account for a significant proportion of total apo B, and were probably due t o a small Endothelium-dependent relaxation is mediated by the release of nitric oxide (EDNO) derived from the vascular endothelium [ 11. In atherosclerotic arteries and those exposed to hypercholesterolaemia, the EDNO response is attenuated [2, 31. Studies in our laboratory 141, have shown that Cuz +-oxidized low-density lipoprotein (OXLDL), inhibits endothelium-dependent relaxations mediated by nitric oxide in the rabbit aorta and may therefore account for the attenuation of vasodilation in atherosclerotic arteries. This conclusion is consistent with the presence of OXLDL in atherosclerotic lesions [ 5 ] . The aim of this work was to determine whether the inhibior was lyosphosphatidylcholine (LPC) as postulated by Kugiyama et al. 161. LDL and high-density lipoproteins (HDL) were prepared separately from the plasma of each volunteer by density gradient ultracentrifugation [4] . HDL were further purified by heparin-Sepharose chromatography [ 71. Oxidation of LDL was achieved by incubation of fresh LDL for 2 h at 37°C with 5 ~M -C U ? + [ 51. Phospholipasc A, (PLA,)-treated LIIL containing LPC was prepared by the incubation of fresh LDL ( 1 mg of protein/ml) with 10 units of PLA, (Sigma, Nuju riaju venom) in 1 ml of 100 mM-Tris buffer (pH 7.4) containing 2 mM-CaClz. The enzyme itself had no effect.
The bioassay of EDNO from isolated rabbit aortic rings was performed as previously described [4] . Aortic rings were precontracted with phenylephrine and relaxed by cumulative concentrations of acetylcholine ( ACh). Preincubation with OXLDL ( 2 mg of protein/ml for maximum inhibition 141) for 30 min inhibited the maximum relaxation (at 1 pM-ACh) irreversibly by 60% whereas fresh LDL caused no inhibition.
Abbreviations used: EDNO. endothelial nitric oxide; LPC. lysophosphatidylcholine; HDL, high-density lipoprotein; OXLDL. oxidized low-density lipoproteins; PLA?. phospholipase A?; ACh. ncetylcholine.
Addition of HDL at concentrations of 1 and 2 mg of protein/ ml, with the OXLDL, reduced the inhibition by 50% and 100%, respectively. Similarly, serum albumin ( 1 .5 mg/ml) caused a 66% decrease in the inhibition by OXLDL (2 mgprotein/ml) whereas inhibition by a lower concentration of OXLDL ( 1 mg of protein/ml) was completely abolished.
The inhibition by HDL and serum albumin suggested that lipid or fatty acid component(s) of the OXLDL might be the factor(s) implicated in the inhibition of relaxation. As LPC is generated by an endogenous PLA, during the modification of LDL 151, the effect of PLA,-treated LDL on relaxations was investigated. The finding that PLA2-treated LDL (0.1 mg of protein/ml; 0.35 _+ 0.05 pmol LPC/mg o f protein) inhibited relaxations completely, indicated that a fatty acid or lysophospholipid present in OXLDL might be the inhibitor(s). This effect required no preincubation and was partially revcrsible.
The effect of I-palmitoyl-LPC on relaxations evoked by ACh was also examined. This lysolipid abolished the relaxations at a concentration of 10 p~ and the effect was reversible. At concentrations of 30-50 p~, inhibition was irreversible due to removal of the endothelium.
The degree o f inhibition of relaxation by OXLDL and its reversibility varied reproducibly with the donor of the plasma from which LDL was prepared 141. If LPC is the inhibitory component of OXLDL, its concentration in the lipoproteins should correlate with the inhibitory potency of 
